Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015168 |
---|---|
Receipt number | R000017287 |
Scientific Title | Investigation of optimal regimen of Fulvestrant in patients with postmenopausal ER-positive advanced recurrent breast cancer |
Date of disclosure of the study information | 2014/09/16 |
Last modified on | 2021/08/06 08:24:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/09/16 09:43:56 | ||
2 | Update | 2014/09/25 16:26:45 | UMIN ID1 |
|
3 | Update | 2015/01/14 16:05:02 | Recruitment status |
|
4 | Update | 2015/03/20 13:12:49 | Institutions |
|
5 | Update | 2015/04/16 11:25:11 | Institutions |
|
6 | Update | 2015/04/16 11:25:50 | Recruitment status |
|
7 | Update | 2015/09/16 17:39:15 | Organization Organization Division name Division name Address Address |
|
8 | Update | 2016/07/08 15:31:55 | Name of primary person or sponsor Organization |
|
9 | Update | 2016/09/28 09:29:55 | Publication of results |
|
10 | Update | 2018/08/23 15:16:47 | Recruitment status Last follow-up date |
|
11 | Update | 2018/08/23 17:44:10 | Public title |
|
12 | Update | 2018/08/24 10:10:07 | UMIN ID1 |
|
13 | Update | 2019/09/05 15:23:54 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
14 | Update | 2019/09/05 15:27:56 | Number of participants that the trial has enrolled |
|
15 | Update | 2019/09/05 15:35:54 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete |
|
16 | Update | 2019/09/05 15:36:47 | Results Delayed Results Delay Reason Results Delay Reason |
|
17 | Update | 2021/03/08 11:11:28 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
18 | Update | 2021/03/08 11:42:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Organization Organization Name of secondary funder(s) Name of secondary funder(s) |
|
19 | Update | 2021/06/16 15:31:41 | Last name of contact person Last name of contact person Division name Name of person sending information Name of person sending information Organization Division name Institute |
|
20 | Update | 2021/06/21 17:54:41 | Homepage URL |
|
21 | Update | 2021/08/06 08:24:51 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |